© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 12, 926-935,
June 19, 2002
© 2002 Oxford University Press
ARTICLE |
Tumorigenesis and Aberrant Signaling in Transgenic Mice Expressing the Human Herpesvirus-8 K1 Gene
Affiliations of authors: O. Prakash, Z.-Y. Tang, X. Peng, R. Coleman (Laboratory of Molecular Oncology), J. Gill, G. Farr (Department of Pathology), Ochsner Clinic Foundation, New Orleans, LA; F. Samaniego, Department of Lymphoma/Myeloma and Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston.
Correspondence to: Om Prakash, Ph.D., Laboratory of Molecular Oncology, Ochsner Clinic Foundation, 1516 Jefferson Hwy., New Orleans, LA 70121 (e-mail: oprakash{at}ochsner.org).
Background: The K1 gene of human herpesvirus-8 (HHV-8; also known as Kaposi's sarcoma-associated herpesvirus) encodes a transmembrane signaling protein that elicits cellular activation events. To evaluate the potential role of K1 in HHV-8-associated pathogenesis, we produced transgenic mice expressing the HHV-8 K1 gene under the transcriptional control of the simian virus 40 promoter. Methods: Three independent heterozygous transgenic K1 mouse lines were generated from founder mice. Mouse splenic and thymic lymphocytes and tumor tissues were analyzed for the expression of cytokines involved in inflammatory and immune responses, including tumor necrosis factor-
(TNF-), interleukin 6 (IL-6), basic fibroblast growth factor (bFGF), and interleukin 12 (IL-12); for the activation of the transcription factors nuclear factor-
B (NF-B) and the B cell-specific transcription factor Oct-2; and for the activation of the Src and Syk family kinases, components of B-cell receptor-induced signal-transduction pathways. Results: Expression of bFGF was increased in K1-transgenic mice as compared with nontransgenic mice, whereas expression of TNF- and IL-6 did not differ using reverse transcriptase–polymerase chain reaction. K1-transgenic mice showed substantially less serum IL-12 induction than did nontransgenic mice when challenged with a lipopolysaccharide. B lymphocytes from K1-transgenic mice but not from nontransgenic mice showed constitutive activation of NF-B and Oct-2. K1 expression in human B lymphocytes stimulated NF-B-dependent promoter activity. B lymphocytes from K1-transgenic mice also showed increased phosphorylation of Lyn, a Src family tyrosine kinase, and enhanced Lyn activity. Tumors in K1-transgenic mice showed features indicative of a spindle-cell sarcomatoid tumor and a malignant plasmablastic lymphoma. The pattern of cytokine, transcription factor, and Lyn kinase activity in the lymphoma was similar to that in B lymphocytes from K1-transgenic mice. Conclusion: K1 may be involved in the activation of NF-B signaling. The enhanced NF-B activity in nonmalignant lymphocytes of K1 mice and its persistence in lymphoma tumors of these mice suggest that the K1 mouse may be a model of premalignancy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. C. Tomlinson and B. Damania Critical Role for Endocytosis in the Regulation of Signaling by the Kaposi's Sarcoma-Associated Herpesvirus K1 Protein J. Virol., July 1, 2008; 82(13): 6514 - 6523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wang, S. Wang, H. Maeng, D. P. Young, O. Prakash, L. E. Fayad, A. Younes, and F. Samaniego K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis Blood, March 1, 2007; 109(5): 2174 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stebbing, T. Powles, M. Nelson, and M. Bower Significance of Variation Within HIV, EBV, and KSHV Subtypes. J Int Assoc Physicians AIDS Care (Chic Ill), September 1, 2006; 5(3): 93 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 M. M. Brinkmann and T. F. Schulz Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1047 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Verma, K. Lan, T. Choudhuri, and E. S. Robertson Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Modulates K1 Expression through Its cis-Acting Elements within the Terminal Repeats. J. Virol., April 1, 2006; 80(7): 3445 - 3458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Goriely, C. Molle, M. Nguyen, V. Albarani, N. O. Haddou, R. Lin, D. De Wit, V. Flamand, F. Willems, and M. Goldman Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation Blood, February 1, 2006; 107(3): 1078 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Parsons Kinase Lynks to herpesvirus lymphomagenesis Blood, May 15, 2005; 105(10): 3762 - 3762. [Full Text] [PDF]
|
|
|
|
|
|
O. Prakash, O. R. Swamy, X. Peng, Z.-Y. Tang, L. Li, J. E. Larson, J. C. Cohen, J. Gill, G. Farr, S. Wang, et al. Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis Blood, May 15, 2005; 105(10): 3987 - 3994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Uddin, A. R. Hussain, K. A. Al-Hussein, P. S. Manogaran, A. Wickrema, M. I. Gutierrez, and K. G. Bhatia Inhibition of Phosphatidylinositol 3'-Kinase/AKT Signaling Promotes Apoptosis of Primary Effusion Lymphoma Cells Clin. Cancer Res., April 15, 2005; 11(8): 3102 - 3108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sugaya, T. Watanabe, A. Yang, M. F. Starost, H. Kobayashi, A. M. Atkins, D. L. Borris, E. A. Hanan, D. Schimel, M. A. Bryant, et al. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter Blood, March 15, 2005; 105(6): 2356 - 2363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Douglas, B. Dutia, S. Rhind, J. P. Stewart, and S. J. Talbot Expression in a Recombinant Murid Herpesvirus 4 Reveals the In Vivo Transforming Potential of the K1 Open Reading Frame of Kaposi's Sarcoma-Associated Herpesvirus J. Virol., August 15, 2004; 78(16): 8878 - 8884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, N. Wakisaka, C. C Tomlinson, S. M DeWire, S. Krall, J. S Pagano, and B. Damania The Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) K1 Protein Induces Expression of Angiogenic and Invasion Factors Cancer Res., April 15, 2004; 64(8): 2774 - 2781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Tomlinson and B. Damania The K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus Activates the Akt Signaling Pathway J. Virol., February 15, 2004; 78(4): 1918 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Sun, S. Zachariah, and P. M. Chaudhary The Human Herpes Virus 8-Encoded Viral FLICE-inhibitory Protein Induces Cellular Transformation via NF-{kappa}B Activation J. Biol. Chem., December 26, 2003; 278(52): 52437 - 52445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Deguchi, D. Whitaker-Menezes, S. C. Jones, S. Aiba, S. Nakagawa, H. Tagami, R. Korngold, and G. F. Murphy 12E2: A Cloned Murine Dermal Cell with Features of Dermal Dendrocytes and Capacity to Produce Pathologic Changes Resembling Early Kaposi's Sarcoma Am. J. Pathol., November 1, 2003; 163(5): 1817 - 1825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Field, W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff, and M. Collins KSHV vFLIP binds to IKK-{gamma} to activate IKK J. Cell Sci., September 15, 2003; 116(18): 3721 - 3728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stebbing, D. Bourboulia, M. Johnson, S. Henderson, I. Williams, N. Wilder, M. Tyrer, M. Youle, N. Imami, T. Kobu, et al. Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes J. Virol., April 1, 2003; 77(7): 4306 - 4314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and W. K. Hong Cancer Prevention Science and Practice Cancer Res., September 15, 2002; 62(18): 5119 - 5125. [Full Text] [PDF]
|
|